Clinical trial

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

NCT00144521

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-02-01

PhasePHASE3

Study timeline

Study start (unknown)2004-02-01Date precision: month

Registry last updated2009-02-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

MRA(Tocilizumab)DRUG

MRA placeboDRUG

MTXDRUG

MTX placeboDRUG

Sponsors & collaborators

Chugai Pharmaceuticallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00144521 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.